Reacting to strong customer demand, Michelson Diagnostics Ltd
(MDL) is broadening the commercial application of its unique multibeam
Optical Coherence Tomography (OCT) technology into
markets outside its core target of cancer diagnosis. These include
such diverse areas as industrial metrology, product inspection, tissue
engineering and developmental biology.
We are reacting to customers who have realised that the superior
image definition provided by our patented multi-beam OCT
technology is very advantageous in their applications, said MDL
CEO Jon Holmes. For a given depth of focus, you get twice the
resolution, (or, for a given resolution, four times the focal depth),
compared with single beam OCT systems which means crisper,
clearer images. He cited applications such as MEMS metrology,
inspection of ceramic composite materials and industrial coatings,
fine art conservation, gemstone quality, stem cell research and
dentistry as examples.
The company currently markets the EX1301 OCT microscope, the
only commercially available OCT product with < 10 ìm lateral
resolution, by virtue of its multi-beam optical design.
Holmes is keen to emphasise that medical imaging remains a central
objective of MDL. We are developing clinical products for launch in
2009, he said, and we are looking for business partners with
experience in other fields to collaborate with or license to, allowing us
to maintain our focus on cancer.
MDL, which has offices in Kent and the West Midlands, was founded
in 2006 by Jon Holmes and four other ex-employees of Sira, the
photonics instrumentation company.